8YY.SI - Biolidics Limited

SES - SES Delayed Price. Currency in SGD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-4,918
-9,374
-5,984
-4,651
-4,810
Depreciation & amortisation
1,285
1,183
1,252
996.335
639.743
Stock-based compensation
0.343
-67
44.343
1,368
-
Change in working capital
206.979
178
-390.021
-871.331
-563.487
Inventory
-14.825
115
-393.825
-785.148
-353.802
Other working capital
-3,819
-3,156
-5,184
-2,881
-5,244
Other non-cash items
120.91
138
227.91
707.012
-97.092
Net cash provided by operating activities
-3,431
-3,063
-4,622
-2,431
-4,557
Cash flows from investing activities
Investments in property, plant and equipment
-387.86
-93
-561.86
-449.448
-686.132
Acquisitions, net
-
-
0
-89.979
-
Other investing activities
98
98
-300
-
-
Net cash used for investing activities
-687.88
5
-860.88
-539.427
-671.132
Net change in cash
-5,445
1,123
-6,648
4,527
-5,487
Cash at beginning of period
5,953
3,960
10,669
6,030
11,499
Cash at end of period
507.986
5,029
3,960
10,669
6,030
Free cash flow
Operating cash flow
-3,431
-3,063
-4,622
-2,431
-4,557
Capital expenditure
-387.86
-93
-561.86
-449.448
-686.132
Free cash flow
-3,819
-3,156
-5,184
-2,881
-5,244